← Leaderboards

Joseph G Sodroski

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗

$53,351,794

Attributed

$58,439,547

Total exposure

28

Grants

18

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$64,635,702 · 29

By mechanism

R01$37,495,096 · 13

R37$11,568,827 · 1

P30$6,572,221 · 3

P01$5,236,084 · 5

R33$1,570,555 · 1

R21$1,148,682 · 3

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Thomas Kieber-Emmons$2,754,963
Amos B Smith$26,356,961
Joseph Hughes$776,098
Donna M Huryn$1,783,438

Others in their field

Top investigators on “Hiv Envelope Protein Gp120”

Barton F Haynes · Duke University$106,842,828
David Heimbrook · Leidos Biomedical Research, Inc.$42,703,445
Richard Thomas Wyatt · Scripps Research Institute, The$19,541,170
Kurt Francis Hauser · University Of Kentucky$19,114,808
Cynthia Ann Derdeyn · Emory University$18,753,159
Thomas N Denny · Duke University$18,530,602

Research focus

Hiv Envelope Protein Gp120CellsViralVirusMediatingHuman Immunodeficiency Virus 1StructureGlycoproteinsNeutralizing AntibodyMolecular ConformationHiv-1Receptor BindingCell MembraneSmall MoleculeSurfaceAntibodiesVirionMembraneComplexConformational ConversionVaccinesInfectionMembrane FusionVariant

Grant awards (132)

Targeting the HIV-1 reservoir at cART initiation with CD4-mimetic interventions$1,363,055

R01 · FY2025 · AI

Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds$825,965

R01 · FY2025 · AI · contact PI

Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein$790,210

R01 · FY2025 · AI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$637,690

R01 · FY2025 · AI · contact PI

Targeting the HIV-1 reservoir at cART initiation with CD4-mimetic interventions$1,314,572

R01 · FY2024 · AI

Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds$825,965

R01 · FY2024 · AI · contact PI

Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein$797,785

R01 · FY2024 · AI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$637,690

R01 · FY2024 · AI · contact PI

Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds$889,028

R01 · FY2023 · AI · contact PI

Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein$825,050

R01 · FY2023 · AI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$637,690

R01 · FY2023 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$637,690

R01 · FY2022 · AI · contact PI

Impact of Env conformational regulation on HIV-1 sensitivity to small-molecule entry inhibitors$344,026

P01 · FY2022 · AI · contact PI

Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein$750,826

R01 · FY2021 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$657,190

R01 · FY2021 · AI · contact PI

Reducing viral reservoirs by opening HIV-1 Env to antibody attack$495,256

R33 · FY2021 · AI · contact PI

Impact of Env conformational regulation on HIV-1 sensitivity to small-molecule entry inhibitors$344,899

P01 · FY2021 · AI · contact PI

Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein$775,468

R01 · FY2020 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$683,064

R01 · FY2020 · AI · contact PI

Reducing viral reservoirs by opening HIV-1 Env to antibody attack$507,917

R33 · FY2020 · AI · contact PI

Impact of Env conformational regulation on HIV-1 sensitivity to small-molecule entry inhibitors$345,743

P01 · FY2020 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$683,064

R01 · FY2019 · AI · contact PI

Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein$681,068

R01 · FY2019 · AI · contact PI

Reducing viral reservoirs by opening HIV-1 Env to antibody attack$567,382

R33 · FY2019 · AI · contact PI

Impact of Env conformational regulation on HIV-1 sensitivity to small-molecule entry inhibitors$346,872

P01 · FY2019 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$683,064

R01 · FY2018 · AI · contact PI

Impact of Env conformational regulation on HIV-1 sensitivity to small-molecule entry inhibitors$292,179

P01 · FY2018 · GM · contact PI

Reducing viral reservoirs by opening HIV-1 Env to antibody attack$242,567

R21 · FY2018 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$697,140

R01 · FY2017 · AI · contact PI

INHIBITOR DISCOVERY, ANTIVIRAL MECHANISM AND BINDING SITE$318,812

P01 · FY2017 · GM · contact PI

Reducing viral reservoirs by opening HIV-1 Env to antibody attack$216,244

R21 · FY2017 · AI · contact PI

Conformational Landscape of the HIV-1 Envelope Glycoproteins$715,679

R01 · FY2016 · AI · contact PI

INHIBITOR DISCOVERY, ANTIVIRAL MECHANISM AND BINDING SITE$318,812

P01 · FY2016 · GM · contact PI

HIV-1 Envelope Glycoproteins$836,610

R37 · FY2015 · AI · contact PI

Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers$437,500

R01 · FY2015 · AI · contact PI

INHIBITOR DISCOVERY, ANTIVIRAL MECHANISM AND BINDING SITE$321,898

P01 · FY2015 · GM · contact PI

HIV-1 Envelope Glycoproteins$836,610

R37 · FY2014 · AI · contact PI

Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers$437,500

R01 · FY2014 · AI · contact PI

Antiretroviral activity of TRIM5alpha$430,652

R01 · FY2014 · AI · contact PI

INHIBITOR DISCOVERY, ANTIVIRAL MECHANISM AND BINDING SITE$346,850

P01 · FY2014 · GM · contact PI

HIV-1 Envelope Glycoproteins$786,415

R37 · FY2013 · AI · contact PI

Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers$411,250

R01 · FY2013 · AI · contact PI

Antiretroviral activity of TRIM5alpha$404,814

R01 · FY2013 · AI · contact PI

INHIBITOR DISCOVERY, ANTIVIRAL MECHANISM AND BINDING SITE$346,850

P01 · FY2013 · GM · contact PI

Broad-range Inhibitors of Human Immunodeficiency Virus Entry$42,438

R03 · FY2013 · DA · contact PI

HIV-1 Envelope Glycoproteins$883,218

R37 · FY2012 · AI · contact PI

Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers$437,500

R01 · FY2012 · AI · contact PI

Antiretroviral activity of TRIM5alpha$430,652

R01 · FY2012 · AI · contact PI

Broad-range Inhibitors of Human Immunodeficiency Virus Entry$43,750

R03 · FY2012 · DA · contact PI

HIV-1 Envelope Glycoproteins$26,404

R37 · FY2012 · AI · contact PI

HIV-1 Envelope Glycoproteins$836,943

R37 · FY2011 · AI · contact PI

Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers$437,500

R01 · FY2011 · AI · contact PI

Antiretroviral activity of TRIM5alpha$431,981

R01 · FY2011 · AI · contact PI

Structure-based antagonism of HIV-1 Envelope Function in Cell Entry$231,159

P01 · FY2011 · GM · contact PI

HIV-1 Envelope Glycoproteins$809,635

R37 · FY2010 · AI · contact PI

Antiretroviral activity of TRIM5alpha$435,000

R01 · FY2010 · AI · contact PI

Structure-based antagonism of HIV-1 Envelope Function in Cell Entry$234,135

P01 · FY2010 · GM · contact PI

HIV-1 Envelope Glycoproteins$796,256

R37 · FY2009 · AI · contact PI

Antiretroviral Activity of TRIM5alpha$397,645

R01 · FY2009 · AI · contact PI

Structure-based antagonism of HIV-1 Envelope Function in Cell Entry$229,733

P01 · FY2009 · GM · contact PI

HIV-1 Envelope Glycoproteins$775,335

R37 · FY2008 · AI · contact PI

Antiretroviral Activity of TRIM5alpha$397,645

R01 · FY2008 · AI · contact PI

Structure of the Retroviral Restriction Factor, TRIM5alpha$248,839

R21 · FY2008 · AI · contact PI

Structure-based antagonism of HIV-1 Envelope Function in Cell Entry$223,051

P01 · FY2008 · GM · contact PI

HIV-1 Envelope Glycoproteins$769,644

R37 · FY2007 · AI · contact PI

Antiretroviral Activity of TRIM5alpha$405,347

R01 · FY2007 · AI · contact PI

Molecular Studies of HIV1 Neutralizing Antibodies$405,347

R01 · FY2007 · AI · contact PI

Structure of the Retroviral Restriction Factor, TRIM5alpha$213,750

R21 · FY2007 · AI · contact PI

Structure-based antagonism of HIV-1 Envelope Function in Cell Entry$210,997

P01 · FY2007 · GM · contact PI

HIV-1 Envelope Glycoproteins$769,282

R37 · FY2006 · AI · contact PI

Structural Analysis of HIV1 Envelope Glycoproteins$594,734

R01 · FY2006 · AI · contact PI

Antiretroviral Activity of TRIM5alpha$417,454

R01 · FY2006 · AI · contact PI

Molecular Interaction Between HIV1 gp120-CD4 Complexes$417,454

R01 · FY2006 · AI · contact PI

Molecular Studies of HIV1 Neutralizing Antibodies$417,454

R01 · FY2006 · AI · contact PI

CORE--VIROLOGY AND BIOLOGY FACILITY$157,210

P01 · FY2006 · GM · contact PI

HIV-1 ENVELOPE GLYCOPROTEINS$639,876

R37 · FY2005 · AI

Structural Analysis of HIV1 Envelope Glycoproteins$594,982

R01 · FY2005 · AI

Molecular Interaction Between HIV1 gp120-CD4 Complexes$427,500

R01 · FY2005 · AI

Antiretroviral Activity of TRIM5alpha$427,500

R01 · FY2005 · AI

Molecular Studies of HIV1 Neutralizing Antibodies$416,030

R01 · FY2005 · AI

HIV-1 ENVELOPE GLYCOPROTEINS$621,326

R37 · FY2004 · AI

Structural Analysis of HIV1 Envelope Glycoproteins$578,429

R01 · FY2004 · AI

REPLICATION AND PATHOGENICITY OF HIV/SIV CHIMERAE$533,706

R01 · FY2004 · AI

Molecular Interaction Between HIV1 gp120-CD4 Complexes$427,500

R01 · FY2004 · AI

Molecular Studies of HIV1 Neutralizing Antibodies$416,364

R01 · FY2004 · AI

HIV-1 Oligomeric Envelope-Proteoliposomes$342,000

R01 · FY2004 · AI

TOPOLOGICAL ANALYSIS OF HIV-1 ENVELOPE GLYCOPROTEINS$341,940

R01 · FY2004 · AI

A STUDY TO DETERMINE THE REPLICATIVE/PATHOLOGIC ABILITY OF CHIMERIC SIV/HIV$105,323

P51 · FY2004 · RR

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH$1,619,026

P30 · FY2003 · AI

HIV-1 ENVELOPE GLYCOPROTEINS$603,316

R37 · FY2003 · AI

Structural Analysis of HIV1 Envelope Glycoproteins$562,349

R01 · FY2003 · AI

REPLICATION AND PATHOGENICITY OF HIV/SIV CHIMERAE$520,059

R01 · FY2003 · AI

Molecular Interaction Between HIV1 gp120-CD4 Complexes$427,500

R01 · FY2003 · AI

Molecular Studies of HIV1 Neutralizing Antibodies$415,829

R01 · FY2003 · AI

HIV-1 Oligomeric Envelope-Proteoliposomes$342,000

R01 · FY2003 · AI

TOPOLOGICAL ANALYSIS OF HIV-1 ENVELOPE GLYCOPROTEINS$331,974

R01 · FY2003 · AI

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH$1,545,655

P30 · FY2002 · AI

HIV-1 ENVELOPE GLYCOPROTEINS$586,400

R37 · FY2002 · AI

Structural Analysis of HIV1 Envelope Glycoproteins$550,001

R01 · FY2002 · AI

REPLICATION AND PATHOGENICITY OF HIV/SIV CHIMERAE$506,762

R01 · FY2002 · AI

Molecular Interaction Between HIV1 gp120-CD4 Complexes$427,605

R01 · FY2002 · AI

TOPOLOGICAL ANALYSIS OF HIV-1 ENVELOPE GLYCOPROTEINS$322,498

R01 · FY2002 · AI

MOLECULAR STUDIES OF HIV1 NEUTRALIZING ANTIBODIES$298,883

R01 · FY2002 · AI

ADAPTION OF HIV VECTORS TO NONPRIMATES$284,242

P50 · FY2002 · HL

HIV-1 Oligomeric Envelope-Proteoliposomes$171,000

R01 · FY2002 · AI

CORE--VIROLOGY AND BIOLOGY FACILITY$157,210

P01 · FY2002 · GM

CORE--VIROLOGY AND BIOLOGY FACILITY$157,210

P01 · FY2002 · GM

CORE--DEVELOPMENTAL FACILITY$0

P30 · FY2002 · AI

CORE--BIOHAZARD CONTAINMENT FACILITY$0

P30 · FY2002 · AI

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH$1,539,397

P30 · FY2001 · AI

HIV-1 ENVELOPE GLYCOPROTEINS$518,067

R37 · FY2001 · AI

STRUCTURAL ANALYSIS OF HIV1 ENVELOPE GLYCOPROTEINS$501,136

R01 · FY2001 · AI

REPLICATION AND PATHOGENICITY OF HIV/SIV CHIMERAE$493,810

R01 · FY2001 · AI

MOLECULAR INTERACTION BETWEEN HIV1 GP120-CD4 COMPLEXES$355,844

R01 · FY2001 · AI

TOPOLOGICAL ANALYSIS OF HIV-1 ENVELOPE GLYCOPROTEINS$313,555

R01 · FY2001 · AI

MOLECULAR STUDIES OF HIV1 NEUTRALIZING ANTIBODIES$290,264

R01 · FY2001 · AI

ADAPTION OF HIV VECTORS TO NONPRIMATES$284,242

P50 · FY2001 · HL

CORE--VIROLOGY AND BIOLOGY FACILITY$157,210

P01 · FY2001 · GM

CORE--DEVELOPMENTAL FACILITY$0

P30 · FY2001 · AI

CORE--BIOHAZARD CONTAINMENT FACILITY$0

P30 · FY2001 · AI

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCH$1,492,077

P30 · FY2000 · AI

STRUCTURAL ANALYSIS OF HIV1 ENVELOPE GLYCOPROTEINS$486,623

R01 · FY2000 · AI

REPLICATION AND PATHOGENICITY OF HIV/SIV CHIMERAE$481,191

R01 · FY2000 · AI

HIV-1 ENVELOPE GLYCOPROTEINS$473,490

R37 · FY2000 · AI

MOLECULAR INTERACTION BETWEEN HIV1 GP120-CD4 COMPLEXES$345,553

R01 · FY2000 · AI

TOPOLOGICAL ANALYSIS OF HIV-1 ENVELOPE GLYCOPROTEINS$306,431

R01 · FY2000 · AI

ADAPTION OF HIV VECTORS TO NONPRIMATES$284,242

P50 · FY2000 · HL

MOLECULAR STUDIES OF HIV1 NEUTRALIZING ANTIBODIES$281,896

R01 · FY2000 · AI

VACCINE VECTORS BASED ON HIV-1$227,282

R21 · FY2000 · AI

CORE--DEVELOPMENTAL FACILITY$188,033

P30 · FY2000 · AI

CORE--BIOHAZARD CONTAINMENT FACILITY$188,033

P30 · FY2000 · AI

CORE--VIROLOGY AND BIOLOGY FACILITY$151,228

P01 · FY2000 · GM